Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038872
Filing Date
2019-08-09
Accepted
2019-08-09 16:01:55
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv526747_10q.htm 10-Q 414865
2 EXHIBIT 31.1 tv526747_ex31-1.htm EX-31.1 11766
3 EXHIBIT 31.2 tv526747_ex31-2.htm EX-31.2 10819
4 EXHIBIT 32 tv526747_ex32.htm EX-32 7777
11 GRAPHIC tv526747_img01.jpg GRAPHIC 162236
  Complete submission text file 0001144204-19-038872.txt   3922950

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT abeo-20190630.xml EX-101.INS 1072485
6 XBRL TAXONOMY EXTENSION SCHEMA abeo-20190630.xsd EX-101.SCH 27905
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abeo-20190630_cal.xml EX-101.CAL 40213
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abeo-20190630_def.xml EX-101.DEF 94736
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE abeo-20190630_lab.xml EX-101.LAB 219167
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abeo-20190630_pre.xml EX-101.PRE 187736
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 191012937
SIC: 2834 Pharmaceutical Preparations